NCT05788549 Assessment of the Effectiveness of Progressive Relaxation Techniques in Individuals With Ulcerative Colitis Status UNKNOWN Phase NA
NCT05785715 Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT05782907 Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05780723 Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP) Status COMPLETED Phase NA
NCT05771155 Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05767021 A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT05761327 Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis Status COMPLETED Phase NA
NCT05743374 Micronutrient and Additive Modifications May Optimize Diet To Health Status RECRUITING Phase NA
NCT05743153 Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis Status UNKNOWN Phase NA
NCT05743010 A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis Status UNKNOWN Phase PHASE1
NCT05739162 A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase NA
NCT05737836 Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences Status NOT_YET_RECRUITING Phase N/A
NCT05733845 Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease Status RECRUITING Phase NA
NCT05728008 Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis. Status COMPLETED Phase N/A
NCT05722236 IBD Strong Peer2Peer for Self-Management of Psychological Distress Status RECRUITING Phase NA
NCT05719766 Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients Status NOT_YET_RECRUITING Phase NA
NCT05715099 Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease Status UNKNOWN Phase PHASE4
NCT05702879 Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success Status RECRUITING Phase N/A